ArticleFrontiers in immunology2022

Tumor metabolic and secondary lymphoid organ metabolic markers on 18F-fludeoxyglucose positron emission tomography predict prognosis of immune checkpoint inhibitors in advanced lung cancer.

Peng Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.